PubRank

Con Kelleher

Author PubWeight™ 25.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006 7.13
2 Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder. BJU Int 2013 1.47
3 The economic impact of overactive bladder syndrome in six Western countries. BJU Int 2009 1.29
4 Estimation of a preference-based index from a condition-specific measure: the King's Health Questionnaire. Med Decis Making 2007 1.16
5 Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study. BJU Int 2006 1.08
6 A review of adherence to drug therapy in patients with overactive bladder. BJU Int 2008 1.06
7 The current and future burden and cost of overactive bladder in five European countries. Eur Urol 2006 1.06
8 Overactive bladder syndrome in older people. BJU Int 2007 0.99
9 Overactive bladder: Is there a link to the metabolic syndrome in men? Neurourol Urodyn 2010 0.98
10 A review of solifenacin in the treatment of urinary incontinence. Ther Clin Risk Manag 2008 0.98
11 Patient reported outcomes: the ICIQ and the state of the art. Neurourol Urodyn 2010 0.92
12 Symptom severity and QOL scales for urinary incontinence. Gastroenterology 2004 0.92
13 What are the best outcome measures when assessing treatments for LUTD?--achieving the most out of outcome evaluation: ICI-RS 2011. Neurourol Urodyn 2012 0.86
14 Redefining response in overactive bladder syndrome. BJU Int 2007 0.84
15 Disease burden of overactive bladder: quality-of-life data assessed using ICI-recommended instruments. Pharmacoeconomics 2007 0.84
16 Long-term prospective randomized study comparing two different regimens of oxybutynin as a treatment for detrusor overactivity. Eur J Obstet Gynecol Reprod Biol 2005 0.83
17 Establishing the content validity of the King's Health Questionnaire in men and women with overactive bladder in the US. Patient 2011 0.81
18 Laparoscopic nephroureterectomy for adult incontinence caused by functioning ectopic pelvic kidney draining into vagina. J Endourol 2004 0.79
19 Clinical relevance of health-related quality of life outcomes with darifenacin. BJU Int 2008 0.78
20 Long-term benefits of darifenacin treatment for patient quality of life: results from a 2-year extension study. Neurourol Urodyn 2008 0.78
21 Bladder function after radical hysterectomy for cervical cancer. Neurourol Urodyn 2014 0.76
22 Bladder sensations during filling cystometry are different according to urodynamic diagnosis. Neurourol Urodyn 2009 0.75